'Eagerly Awaited' Results of CANVAS

Do SGLT-2 inhibitors reduce the risk for major cardiovascular events? Dr Wysham discusses hot-off-the-press results of the CANVAS program at ADA 2017.

Source: Medscape Diabetes & Endocrinology Podcast - June 21, 2017 Category: Endocrinology Authors: Medscape Source Type: podcasts